Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A small molecule modulating heterogeneous amyloid-β isoforms improves cognitive and pathological outcomes in acute and 5XFAD Alzheimer's disease models.

Alzheimer's research & therapy·2026
Same author

Targeting Lysyl Oxidase-like 2: A Therapeutic Strategy for Idiopathic Pulmonary Fibrosis with a Novel Indolizine Derivative.

Pharmaceutics·2026
Same author

Effects of gyroid lattice relative density on wear and mechanical performance of 3D printed TPU and flexible nylon for footwear.

iScience·2026
Same author

Small Molecule Therapeutics Targeting Amyloid-β in Alzheimer's Disease: Mechanisms, Clinical Progress, and Future Strategies.

Experimental neurobiology·2026
Same author

Targeted Discovery of β‑Branched Conjugated Polyketides from Bacteria Based on Genomic and Metabolomic Hallmarks.

JACS Au·2026
Same author

Temporal and regional trends in the diagnosis and treatment of spontaneous intracranial hypotension: a systematic review.

The journal of headache and pain·2026
Same journal

Association of sleep duration with Alzheimer's disease and cognition.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Patient-derived forebrain cortical organoids reveal biphasic tau-MAP6-microtubule axis dysfunction in tauopathy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Genetic architecture of the limbic white matter microstructure in aging and Alzheimer's Disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Greater choroid plexus volume is linked to poor sleep, neurodegeneration, and cognitive deficits in older adults: Evidence from the IGNITE Study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Plasma-based neurobiological protein biomarkers as predictors of dementia progression: Insights from longitudinal aging study in India - Diagnostic assessment of dementia.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Neuropathology-specific language features in primary progressive aphasia.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

YoungSoo Kim1,2, Illhwan Cho2, Sunhee Lee2

  • 1Amyloid Solution Inc., Seongnam, Gyeonggi-do, Korea, Republic of (South).

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
PubMed
概括
此摘要是机器生成的。

一种新的光化合物AS-YFluor可以检测血中的粉样蛋白-β42 (Aβ42) 寡合体. 这种阿尔茨海默病 (AD) 生物标志物检测工具对早期AD诊断和监测疾病进展具有前途.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学领域:

  • 神经科学是一个神经科学.
  • 生物化学 生化学
  • 医学诊断 医学诊断 医学诊断

背景情况:

  • 粉样蛋白-β42 (Aβ42) 寡合体是关键的神经毒性生物标志物,与阿尔茨海默氏症 (AD) 病原和进展有关.
  • 目前用于早期AD的诊断工具和Aβ42寡合体的临床前检测是有限的,这阻碍了临床试验的有效性.
  • 新型成像探针对于阐明Aβ42寡合体的作用和支持早期AD诊断至关重要.

研究的目的:

  • 引入AS-YFluor,一种新型光化合物,旨在选择性检测Aβ42寡合体.
  • 评估AS-YFluor在区分阿尔茨海默病患者与使用血的对照中的诊断潜力.
  • 评估AS-YFluor在监测AD进展和区分各种认知状态中的实用性.

主要方法:

  • 进行了体外试验,以确认AS-YFluor对Aβ42寡合物的选择性.
  • 用5XFAD转基因小鼠和对照的生物样本 (脑溶解物,脑脊液,血液) 来评估诊断潜力.
  • AS-YFluor应用于来自165名人类参与者的血样本 (NC,AD,MCI,非AD痴呆症) 来分析光信号.

主要成果:

  • AS-YFluor对Aβ42寡合体具有很高的特异性,没有与其他蛋白种或丰富的血液蛋白质交叉反应.
  • 该化合物有效地区分了来自5XFAD小鼠和对照小鼠的样本,验证了其在生物矩阵中的使用.
  • 在人类研究中,AS-YFluor高精度地将AD患者与正常对照和非AD痴呆症患者区分开来 (>93%的MCI与AD/NC敏感度和特异性).

结论:

  • AS-YFluor是一种新型光剂,能够选择性地检测阿尔茨海默病患者血液中的Aβ42寡合体水平.
  • 该化合物显示出作为一种基于血液的诊断工具,用于早期AD检测和监测疾病进展的显著前景.
  • AS-YFluor的多功能性扩展到研究寡合体行为的非临床研究应用.